Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis

PLoS One. 2020 Jun 12;15(6):e0234348. doi: 10.1371/journal.pone.0234348. eCollection 2020.

Abstract

Chronic hepatitis B (HBV) remains a significant public health problem in Ghana and past reviews conducted could not calculate a nationwide prevalence of the disease due to lack of primary research for some regions of the country. We therefore conducted this study to summarize and update the available information on HBV infection burden (prevalence) in Ghana from 2015-2019.We systematically searched PubMed, Embase, ScienceDirect, and Google Scholar to retrieve primary studies published in peer-reviewed journals from November 2015 to September 2019, assessing the prevalence of HBV among the Ghanaian populace. The review included 21 studies across all ten old regions of Ghana with a total sample population of 29 061. The HBV prevalence was estimated for subpopulations as follows: 8.36% in the adult population, 14.30% in the adolescent population, and 0.55% in children under five years (pre-school). Among adults, HBV infection prevalence was the highest in the special occupation group (14.40%) and the lowest prevalence rate of 7.17% was recorded among blood donors. Prevalence was lower in the north than in the southern part of the country. The Ashanti region had the most studies at 6/21 (29%), while no study was identified for the Upper West region. Across the country, the highest HBV infection prevalence rates were recorded in the age group of 20-40 years. The burden of hepatitis B is enormous and remains an important public health issue in Ghana. Addressing the issue will require an integrated public health strategy and rethinking of the implementation gaps in the current HBV infection control program. This will help propel the country towards eliminating the disease by 2030.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Adolescent
  • Adult
  • Child, Preschool
  • Female
  • Ghana / epidemiology
  • Hepatitis B / complications
  • Hepatitis B / epidemiology
  • Hepatitis B / prevention & control
  • Hepatitis B Vaccines / pharmacology
  • Hepatitis B, Chronic / complications
  • Hepatitis B, Chronic / epidemiology*
  • Hepatitis B, Chronic / prevention & control
  • Humans
  • Infant
  • Male
  • Pregnancy
  • Pregnancy Complications, Infectious / epidemiology
  • Prevalence
  • Young Adult

Substances

  • Hepatitis B Vaccines

Grants and funding

The National Nature Science Foundation of China (No. 81973709): The Hunan Nature Science Foundation (No. 2019JJ40348).